You are here:
Home / Archives for ACAD
In the United States, up to 50 million people live with chronic pain, with the majority of these patients not satisfied with their current pain treatments. Pain is defined clinically as an unpleasant emotional experience resulting from real or potential tissue damage and is generally divided into two categories based on cause:
Nociceptive pain, which is [...]
Filed under Articles · Tagged with ACAD, ACADIA Pharmaceuticals, ADL5859, ADLR, Adolor Corporation, AEG33773, Aegera Therapeutics, AGN, AGN 0001, AGN XX/YY, Allergan, alpha tocopheryl phosphate, AV411, AVGN, Avigen, axomadol, BIIB, Biogen Idec, Endo Pharmaceuticals, ENDP, ExonHit Therapeutics, gabapentin enacarbil, GlaxoSmithKline, Grunenthal, GSK, ICA-105665, Icagen, ICGN, ion channel, NAV1.7, Neublastin, Neuropathic Pain, Newron Pharmaceutics, Nitec Pharma AG, nociceptive, NsGene A/S, PFE, Pfizer, Phosphagenics Limited, TruNoc, Xenoport, XNPT, XP13512
